Lumito secures loan of SEK 20 million and carries out an issue of warrants free-of-charge to shareholders and the lender
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER […]
Lumito attends the Digital Pathology & AI Congress in London
On December 7–8, Lumito will exhibit with a booth at the annual Digital Pathology & AI Congress in London. The presence is part of the company's branding work within the company's primary target group ahead of the upcoming launch of SCIZYS. – It is important for us to build trust around our brand and product. […]
Lumito has started an internal pilot study for multiplexing
Lumito has started a pilot study where the aim is to investigate the possibilities of multiplexing by adding another nanoparticle label to the company's unique UCNP-based technology. There is a pronounced need from the market regarding requests for multiplexing to facilitate further and streamline the work within tissue analysis. Lumito already offers multiplexing with today's […]
Lumito AB publishes Quarterly Report 3, 2023
Financial overview of the third quarterJuly 1 to September 30, 3023 Net sales amounted to TSEK 0 (0). Result after taxes amounted to TSEK -5 358 (-6 815). Earnings per share before and after dilution amounted to SEK -0,03 (-0,04). Cash flow from operating activities after changes in working capital amounted to TSEK -6 101 […]
Watch Mattias Lundin’s presentation at the BioStock Life Science Summit on October 25
On October 25, Mattias Lundin, Lumito's CEO, presented the company and the strategy going forward at the BioStock Life Science Summit in Lund. The presentation can be viewed afterwards here: Lumitos Presentation at the BioStock Life Science Summit October 25, 2023 For further information, please contact: Mattias Lundin, CEO LumitoE-mail: ml@lumito.sePh: +46 76 868 45 09 […]
First factory produced SCIZYS reagent kit is now available
The first batch of Lumito's reagent intended for end customer sales is now produced by Lumito's production partner, Uniogen Oy. Lumito has collaborated with Uniogen Oy (formerly Kaivogen Oy) for over 15 months to prepare the production of the nanoparticle-based reagent kit belonging to the company's digital pathology solution. – It feels great that a […]
Lumito presents at the BioStock Life Science Summit
On October 25 at 1 p.m., Mattias Lundin, Lumito's CEO, presents the company at the BioStock Life Science Summit 2023 and answers questions from the moderator. Where: Medicon Village, LundWhen: October 25 at 1 p.m.Registration: https://www.biostock.se/en/biostocklifesciencesummit/ The presentation will be held in English. Tickets to the event are free of charge. The presentation will not be broadcast […]
Dr. Gopalakrishnan and Lumito’s poster receives third place at R&D Summit: Institutes for Excellence Launch at UHCW NHS Trust
Friday September 15th, Lumito was awarded third place in a poster competition during the R&D Summit at the UHCW NHS Trust. The poster, entitled "Utility of Upconversion Nanoparticles (UCNP) Based Immunohistochemistry in Diagnostic Renal Biopsies – A Proof of Concept Study", is the poster presented in June at the Liverpool Pathology 2023 congress by Dr. […]
Successful presence for Lumito at the European Congress of Pathology
Lumito exhibited with a booth at the European Congress of Pathology in Dublin on September 10–12. The congress gathered a total of 4,448 people, and the interest in Lumito's booth was excellent. An increased interest was also shown from repeat visitors and potential distributors. The European Congress of Pathology ranks as one of Europe's leading […]
Lumito signs an agreement with Uniogen Oy
Lumito AB and the Finnish company Uniogen Oy have signed a cooperation agreement for the production of Lumito’s immunohistochemical reagent kit, SCIZYS Erbium Kit. The reagent kit is part of Lumito’s product offering and is based on upconverted nanoparticles. Since June 2022, Lumito has had a Letter of Intent in place with Uniogen Oy (formerly […]
